Research Article

Association between Duration of Exercise (MET Hours per Week) and the Risk of Decreased eGFR: A Cross-Sectional Study Based on a Large Chinese Population

Table 4

Correlation analysis between physical activity (MET hours per week) and the risk of decreased eGFR in subgroups.

VariableNonadjusted trendModel I trendModel II trend

MaleeGFR category
Physical activity (MET hours per week)0.26920.03100.0035
<7.51.01.01.0
7.5 to <211.27 (1.12, 1.44)1.05 (0.90, 1.23)1.05 (0.89, 1.25)
≥211.10 (1.00, 1.20)1.13 (1.01, 1.26)1.18 (1.05, 1.34)
Continuous eGFR (mL/min/1.73 m2)
Physical activity (MET hours per week)0.14640.89810.1057
<7.5000
7.5 to <21-1.95 (-2.95, -0.96)-0.18 (-0.94, 0.59)-0.16 (-0.92, 0.60)
≥210.08 (-0.63, 0.80)-0.00 (-0.56, 0.55)-0.43 (-0.98, 0.13)
FemaleeGFR category
Physical activity (MET hours per week)0.5679<0.00010.0001
<7.51.01.01.0
7.5 to <211.19 (1.04, 1.37)1.25 (1.05, 1.48)1.25 (1.04, 1.49)
≥211.01 (0.91, 1.12)1.34 (1.17, 1.52)1.33 (1.15, 1.52)
Continuous eGFR (mL/min/1.73 m2)
Physical activity (MET hours per week)0.01430.0001<0.0001
<7.5000
7.5 to <21-1.16 (-1.68, -0.64)-0.74 (-1.21, -0.26)-0.53 (-1.00, -0.07)
≥21-0.63 (-1.01, -0.25)-0.74 (-1.08, -0.39)-0.75 (-1.09, -0.41)
yearseGFR category
Physical activity (MET hours per week)0.03510.05490.2080
<7.51.01.01.0
7.5 to <211.19 (0.89, 1.60)1.11 (0.82, 1.50)1.16 (0.82, 1.64)
≥211.26 (1.02, 1.57)1.23 (0.99, 1.53)1.20 (0.93, 1.55)
Continuous eGFR (mL/min/1.73 m2)
Physical activity (MET hours per week)0.01720.17140.0031
<7.5000
7.5 to <21-0.94 (-1.39, -0.49)-0.37 (-0.77, 0.03)-0.53 (-0.84, -0.22)
≥21-0.50 (-0.82, -0.19)-0.24 (-0.52, 0.04)-0.30 (-0.52, -0.08)
Age 55-64 yearseGFR category
Physical activity (MET hours per week)<0.0001<0.0001<0.0001
<7.51.01.01.0
7.5 to <211.05 (0.92, 1.21)1.04 (0.90, 1.20)1.09 (0.91, 1.31)
≥211.22 (1.11, 1.35)1.24 (1.12, 1.38)1.26 (1.10, 1.45)
Continuous eGFR (mL/min/1.73 m2)
Physical activity (MET hours per week)<0.0001<0.0001<0.0001
<7.5000
7.5 to <21-0.69 (-1.35, -0.02)-0.71 (-1.36, -0.06)-0.70 (-1.28, -0.12)
≥21-1.22 (-1.71, -0.73)-1.22 (-1.71, -0.74)-1.06 (-1.49, -0.63)
yearseGFR category
Physical activity (MET hours per week)0.78880.24450.7046
<7.51.01.01.0
7.5 to <211.11 (0.96, 1.28)1.18 (1.01, 1.37)1.15 (0.95, 1.38)
≥211.05 (0.94, 1.17)1.23 (1.10, 1.38)1.15 (1.00, 1.32)
Continuous eGFR (mL/min/1.73 m2)
Physical activity (MET hours per week)0.63760.77330.9339
<7.5000
7.5 to <21-0.52 (-2.24, 1.20)-1.15 (-2.80, 0.50)-0.31 (-1.73, 1.11)
≥21-0.51 (-1.81, 0.78)-2.43 (-3.69, -1.17)-1.22 (-2.32, -0.13)
NondiabeteseGFR category
Physical activity (MET hours per week)0.0001<0.0001<0.0001
<7.51.01.01.0
7.5 to <211.23 (1.09, 1.39)1.13 (0.98, 1.30)1.18 (0.99, 1.41)
≥211.21 (1.11, 1.32)1.39 (1.25, 1.55)1.42 (1.24, 1.62)
Continuous eGFR (mL/min/1.73 m2)
Physical activity (MET hours per week)0.0001<0.0001<0.0001
<7.5000
7.5 to <21-1.48 (-2.11, -0.85)-0.51 (-1.04, 0.02)-0.38 (-0.85, 0.09)
≥21-1.06 (-1.52, -0.60)-1.07 (-1.46, -0.68)-0.78 (-1.12, -0.44)
PrediabeteseGFR category
Physical activity (MET hours per week)0.85180.01130.9813
<7.51.01.01.0
7.5 to <211.21 (1.05, 1.39)1.17 (0.99, 1.38)1.22 (0.71, 2.08)
≥211.05 (0.94, 1.17)1.19 (1.05, 1.35)1.07 (0.71, 1.62)
Continuous eGFR (mL/min/1.73 m2)
Physical activity (MET hours per week)0.07200.00250.2905
<7.5000
7.5 to <21-1.69 (-2.70, -0.68)-0.97 (-1.89, -0.05)-1.70 (-3.46, 0.06)
≥21-0.94 (-1.69, -0.19)-1.11 (-1.79, -0.43)-0.80 (-2.12, 0.51)
DiabeteseGFR category
Physical activity (MET hours per week)0.75550.17620.7344
<7.51.01.01.0
7.5 to <211.05 (0.86, 1.30)1.03 (0.92, 1.16)1.21 (0.94, 1.56)
≥211.03 (0.89, 1.19)1.07 (0.96, 1.19)1.22 (1.00, 1.48)
Continuous eGFR (mL/min/1.73 m2)
Physical activity (MET hours per week)0.52470.88040.4650
<7.5000
7.5 to <21-0.53 (-2.21, 1.15)-0.14 (-1.69, 1.41)0.12 (-1.26, 1.50)
≥210.26 (-0.93, 1.44)0.05 (-1.05, 1.15)0.33 (-0.65, 1.31)

Nonadjusted model for none. Model I adjusted for age and BMI. Model II adjusted for age, sex, BMI, region, education level, SBP, DBP, pulse, LDL, HDL, TG, FBG, PBG, HbA1c, GGT, smoking status, drinking status, history of hypertension, cardiovascular history, diabetes history, medication history, and family history of diabetes and tumor.